Rising Incidence of Chronic Diseases & Availability of Funding for Research will Drives the Cell Signaling Market

Cell Signaling Market

Cell Signaling Market Cell Signaling Market

Pune, India, 2020-Feb-07 — /EPR Network/ —

According to the new market research report Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) – Global Forecast, published by MarketsandMarkets™, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the global market along with the estimates and forecasts of the revenue and market share analysis.

The Cell Signaling Market is expected to reach USD 3.51 Billion, at a CAGR of 6.8%

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=80206120

Growth in the market is driven by the rising incidence of chronic diseases, availability of funding for cell-based research, technological advancements in cell-based research instruments, and the growth of the life science and biopharmaceutical industries.

This report segments the market on the basis of product, pathway, signaling type, technology, application, and region.

Browse and in-depth TOC on  “Cell Signaling Market

157 – Tables

76 – Figures

212 – Pages

Market Segmentation:

By pathway, the market is segmented into AMP-activated protein kinase (AMPK), Akt, ErbB/HER, Hedgehog (Hh), NF-êB, Janus kinase and signal transducer and activator of transcription (JAK/STAT), Notch, and other signaling pathways. The Akt pathway segment is estimated to account for the largest share of the market in 2017.

Based on signaling type, the market is segmented into paracrine, endocrine, autocrine, juxtacrine, and other signaling types (intracrine and neuronal signaling). The endocrine segment is estimated to account for the largest share of the Cell Signaling Market in 2017.

On the basis of technology, the market is segmented into enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), microscopy, flow cytometry, western blotting, mass spectrometry, and other technologies (immunofluorescence and immunoprecipitation). The microscopy segment is estimated to account for the largest share.

Based on application, the market is segmented into research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The research applications segment is estimated to account for the largest share of the Cell Signaling Market in 2017.

Request for Sample Report (Please share your specific interest to serve you better)

https://www.marketsandmarkets.com/requestsampleNew.asp?id=80206120

Geographic Segmentation:

On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2017. Growth in this regional segment is driven by the growth in geriatric population, rising incidence of chronic diseases, and improved life science research infrastructure in the region.

Leading Key Players in the Worldwide Market:

The key players in the Cell Signaling Market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.).

Matched content

Editor’s pick

Do NOT follow this link or you will be banned from the site!